Publications

Perry CS, Garcia S, Collie S, MacDonell M, Adeshina F, Sonich-Mullin C. Application of provisional advisory levels for EPA National Homeland Security Research Center’s secure, internet-based rapid risk tool. Society for Risk Analysis’ Annual Meeting, Orlando, FL, December 2005.

Gentry PR, Haber LT, McDonald TB, Zhao Q, Covington T, Nance P, Clewell HJ III, Lipscomb JC, Barton HA. 2005. Data for physiologically based pharmacokinetic modeling in neonatal animals: Physiological parameters in mice and Sprague-Dawley rats. J Children’s Health 2(3–4):363–411; doi: 10.3109/15417060490970430.

Bailer AJ, Noble RB, Wheeler MW. 2005. Model uncertainty and risk estimation for experimental studies of quantal responses. Risk Anal 25(2):291-9; doi: 10.1111/j.1539-6924.2005.00590.x. PMID: 15876205.

Teeguarden JG, Waechter JM, Clewell HJ, Covington TR, Barton HA. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Kester JE, Gentry P, Covington TR, Clewell HJ. Issues in the use of PBPK modeling in the development of cancer slope factors for perchloroethylene. Poster presented at the Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Covington TR, Clewell HJ, Fisher JW, Keys DA, Hack C, Zhao JQ. A harmonized PBPK model for trichloroethylene risk assessment. Poster presented at the Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Kim DJ, Murray I, Burns AM, Gonzalez FJ, Perdew GH, Peters JM. 2005. Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem 280(10):9519-9527; doi: 10.1074/jbc.M413808200. PMID: 15632134.

Gentry PR, Covington TR, Lawrence G, McDonald T, Snow ET, Germolec D, Moser G, Yager JW, Clewell HJ III. 2005. Comparison of tissue dosimetry in the mouse following chronic exposure to arsenic compounds. J Toxicol Environ Health A 68(5):329–351; 10.1080/15287390590900813.

Truax JF, Choksi NY, Inhof CJ, Allen DG, Tice RR, Stokes WS. Validation status of the Isolated Rabbit Eye (IRE) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005

Allen DG, Choksi NY, Inhof CJ, Truax JF, Tice RR, Stokes WS. Validation status of the Isolated Chicken Eye (ICE) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Inhof CJ, Choksi NY, Allen DG, Truax JF, Tice RR, Stokes WS. Validation status of the Bovine Corneal Opacity and Permeability (BCOP) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Choksi NY, Allen DG, Inhof CJ, Truax JF, Tice RR, Stokes WS. Validation status of the Hen’s Egg Test-Chorioallantoic Membrane (HET-CAM) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Choksi NY, Allen DG, Inhof CJ, Truax JF, Tice RR, Stokes WS. Performance of BCOP, IRE, ICE, and HET-CAM in detecting substances that induce severe irritation and irreversible ocular damage. Presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Haseman JH, Choksi NY, Inhof CJ, Truax JF, Tice RR, Stokes WS. The performance characteristics of the in vivo rabbit eye test. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84(2):225-31; doi: 10.1093/toxsci/kfi090.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Toxicokinetics of BDE 47 in female mice: Effects of dose, route of exposure, and time. Toxicol Sci. 83(2):215-23; doi: 10.1093/toxsci/kfi018.

Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. 2005. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis 26(1):219-227; doi: 10.1093/carcin/bgh285. PMID: 15447978.

Tinkelman D, Nordyke RJ, Isonaka S, George D, DesFosses D, Nonikov D. 2005. The impact of chronic obstructive pulmonary disease on long-term disability costs. J Manag Care Pharm 11(1):25-32; doi: 10.18553/jmcp.2005.11.1.25. PMID: 15667231.

Ponce N, Nordyke RJ, Hirota S. 2005. Uninsured working immigrants: A view from a California county. J Immigr Health 7(1):45-53; doi: 10.1007/s10903-005-1390-0. PMID: 15744477.

Urban JD, Mailman RB. Characterization of the N27 dopaminergic cell line as a model for elucidating the actions of functionally selective dopaminergic ligands. 35th Annual Neuroscience Meeting, Washington, DC, November 2005.